
"Link Between Hormone Treatment and Transmitted Alzheimer's Uncovered"
A study published in Nature Medicine has found evidence linking cadaver-derived human growth hormone (c-hGH) treatment to the development of Alzheimer's disease, marking the first direct connection between a specific medical treatment and the illness. Researchers at University College London (UCL) discovered that c-hGH, no longer used due to safety concerns, can increase levels of the amyloid-beta protein in the brain, a hallmark of Alzheimer's. While the study only identified a small number of patients affected, it raises concerns about potential risks associated with certain medical treatments and suggests the need for further research to confirm these findings.


